Tirzepatide (GLP-1 / GIP Dual Agonist)
A dual-incretin reference compound widely studied in metabolic pathway research.
Drag the vial to rotate the label
By adding to cart, purchaser certifies the materials are being acquired solely for legitimate laboratory research purposes. Not for human or veterinary use.
A dual-incretin reference compound widely studied in metabolic pathway research.
Tirzepatide is a synthetic 39-amino-acid dual agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. Researchers use it in receptor binding, cAMP accumulation, and β-arrestin recruitment assays to compare dual-incretin pharmacology against selective GLP-1R or GIP-R agonists. Its C20 fatty-diacid acylation supports extended in-vitro stability in cultured adipocyte, hepatocyte, and β-cell models. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.
- GLP-1R / GIP-R co-activation assays
- cAMP / β-arrestin recruitment studies
- Metabolic pathway comparison models
- Independently verified for identity and purity on a batch-specific basis.
- Certificates of analysis publicly accessible by lot ID — never averaged.
- Sourced through qualified manufacturing partners and shipped from the United States.
- Fast shipping, always tracked, shipped from the United States.
